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REFLECTION: 
Advocating for our patients using clinical 
research 
BRANDON BAKER, Wayne State University, Detroit, MI, brbaker@med.wayne.edu  
 
I was a first year medical student when I first heard of the so-called “debate” related to screening mammograms. My classmates 
were surprised to learn that there is evidence against performing screening mammograms.1-4 Hearing about the research itself was 
not the most shocking part—it was that this evidence has been widely available, yet nothing has changed. I was so bothered by this 
realization that I continued the conversation at home with my mother, who has had several mammograms in the past. She asked me 
rather bluntly if she should continue to get her mammogram every year. The only thing I could tell her at that time was, “That’s a 
conversation you should have with your doctor.” I had just discussed the latest research on the sub ject, yet I was unable to advise 
her what to do. 
The topic did not resurface for the next two years. As a third year medical student having completed seven months in the hospital, 
including time spent in the breast clinic, I did not once experience the guidelines for screening mammograms presented as 
controversial. I did, however, have an encounter with a patient in my continuity clinic at a family medicine office, in which the topic 
surfaced once again. Only because of my experience during Translational Medicine in my first year at medical school did I feel 
comfortable discussing the current research with this patient on my own. I was amazed, and rather relieved, at how responsive she 
was to hearing about the evidence and being able to make an informed decision about her own health. My supervising physician 
continued this conversation with her. He discussed the research and its implications for her in great detail. In the end, the 
supervising physician told her it was completely up to her whether or not she wanted to schedule a mammogram, even if just for her 
peace of mind. She chose not to, and was very satisfied discussing it all with us to make the right decision for her. As the patient left 
the office, a feeling of accomplishment came over me, knowing that we had done the right thing for our patient.  
I think the reason that practicing physicians are not discussing the latest evidence with patients is the same now as when I began 
medical school: learning something that contradicts what we thought was true can be uncomfortable. Sometimes, doctors do not 
want to go against common practice. It’s easier to follow established procedures without stopping to think, “Is this what is best for 
my patient?” The biggest injustice we do to our patients is to remain comfortable and ignore research evidence. We need to do 
what is in our patients’ best interests by following the evidence, and policies need to change to reflect that evidence. 
References 
1. Miller AB, Wall C, Baines CJ, et al. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National 
Breast Screening Study: randomized screening trial. BMJ. 2014;348:g366. doi:10.1136/bmj.g366 
2. Meza JP. Screening mammography requires informed consent. Clinical Research in Practice: The Journal of Team Hippocrates. 
2015;1(1):eP1027. Retrieved from http://digitalcommons.wayne.edu/crp/vol1/iss1/9/ 
3. Boggs, NE. Defining quality in medical practice (letter to the editor). Clinical Research in Practice: The Journal of Team 
Hippocrates. Feb 5, 2016;2(1):eP1092. Retrieved from http://digitalcommons.wayne.edu/crp/vol2/iss1/2/ 
4. Lin KW, Gostin LO. A public health framework for screening mammography: evidence based vs politically mandated care. JAMA. 
2015;314(15):1599-1614. doi:10.1001/jama.2016.0322 
